Senators accuse Teva, Mylan of stonewalling price fixing probe; Myriad Genetics shares skid on dismal quarterly results
→ US lawmakers have written to Teva $TEVA, Mylan $MYL and privately-held Heritage Pharmaceuticals asking for documents as part of a sweeping congressional probe into generic drug price hikes, accusing the companies of “apparent efforts to stonewall” the investigation, Reuters reported. The probe was first launched in 2014, and earlier this year 44 US states filed a lawsuit alleging drug price-fixing by the trio of drugmakers. Now, senators Elijah Cummings and Bernie Sanders are investigating a purported “coordinated obstruction” of the probe, cited in the State’s complaint, the report said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.